US Stock MarketDetailed Quotes

NNVC Nanoviricides

Watchlist
  • 1.500
  • -0.010-0.66%
Close Dec 27 16:00 ET
  • 1.600
  • +0.100+6.65%
Post 20:01 ET
21.52MMarket Cap-1.97P/E (TTM)

Nanoviricides Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
55.93%3.17M
-4.78%8.52M
-34.95%2.39M
5.39%1.91M
19.13%2.18M
25.22%2.03M
10.23%8.94M
105.07%3.68M
1.28%1.81M
-4.51%1.83M
Selling and administrative expenses
118.57%1.23M
20.69%3.08M
58.40%1.21M
12.87%693.74K
-7.90%610.88K
10.83%564.93K
9.55%2.55M
22.89%763.42K
15.36%614.65K
0.61%663.28K
-General and administrative expense
118.57%1.23M
20.69%3.08M
58.40%1.21M
12.87%693.74K
-7.90%610.88K
10.83%564.93K
9.55%2.55M
22.89%763.42K
15.36%614.65K
0.61%663.28K
Research and development costs
31.80%1.93M
-14.94%5.44M
-59.42%1.18M
1.55%1.21M
34.44%1.57M
31.82%1.47M
10.50%6.39M
148.64%2.91M
-4.70%1.2M
-7.18%1.17M
Operating profit
-55.93%-3.17M
4.78%-8.52M
34.95%-2.39M
-5.39%-1.91M
-19.13%-2.18M
-25.22%-2.03M
-10.23%-8.94M
-105.07%-3.68M
-1.28%-1.81M
4.51%-1.83M
Net non-operating interest income expense
-34.72%41.02K
-37.46%221.97K
-66.75%35.37K
-50.04%53.93K
-21.43%69.82K
21.51%62.85K
5,168.63%354.9K
732.00%106.38K
2,353.85%107.94K
16,024.73%88.86K
Non-operating interest income
-58.70%41.02K
-23.62%271.77K
-66.75%35.37K
-50.04%53.93K
-6.54%83.13K
88.99%99.34K
2,900.53%355.83K
797.04%106.38K
--107.94K
4,191.08%88.95K
Non-operating interest expense
--0
5,210.02%49.81K
--0
--0
14,064.89%13.32K
4,223.82%36.49K
-81.69%938
--0
--0
-96.43%94
Other net income (expense)
Income before tax
-58.82%-3.13M
3.43%-8.29M
34.01%-2.36M
-8.91%-1.85M
-21.19%-2.11M
-25.35%-1.97M
-5.94%-8.59M
-100.56%-3.57M
5.01%-1.7M
9.16%-1.75M
Income tax
Net income
-58.82%-3.13M
3.43%-8.29M
34.01%-2.36M
-8.91%-1.85M
-21.19%-2.11M
-25.35%-1.97M
-5.94%-8.59M
-100.56%-3.57M
5.01%-1.7M
9.16%-1.75M
Net income continuous Operations
-58.82%-3.13M
3.43%-8.29M
34.01%-2.36M
-8.91%-1.85M
-21.19%-2.11M
-25.35%-1.97M
-5.94%-8.59M
-100.56%-3.57M
5.01%-1.7M
9.16%-1.75M
Minority interest income
Net income attributable to the parent company
-58.82%-3.13M
3.43%-8.29M
34.01%-2.36M
-8.91%-1.85M
-21.19%-2.11M
-25.35%-1.97M
-5.94%-8.59M
-100.56%-3.57M
5.01%-1.7M
9.16%-1.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.82%-3.13M
3.43%-8.29M
34.01%-2.36M
-8.91%-1.85M
-21.19%-2.11M
-25.35%-1.97M
-5.94%-8.59M
-100.56%-3.57M
5.01%-1.7M
9.16%-1.75M
Basic earnings per share
-35.29%-0.23
5.41%-0.7
38.71%-0.19
-6.67%-0.16
-20.00%-0.18
-21.43%-0.17
-5.71%-0.74
-106.67%-0.31
6.25%-0.15
11.76%-0.15
Diluted earnings per share
-35.29%-0.23
5.41%-0.7
38.71%-0.19
-6.67%-0.16
-20.00%-0.18
-21.43%-0.17
-5.71%-0.74
-106.67%-0.31
6.25%-0.15
11.76%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 55.93%3.17M-4.78%8.52M-34.95%2.39M5.39%1.91M19.13%2.18M25.22%2.03M10.23%8.94M105.07%3.68M1.28%1.81M-4.51%1.83M
Selling and administrative expenses 118.57%1.23M20.69%3.08M58.40%1.21M12.87%693.74K-7.90%610.88K10.83%564.93K9.55%2.55M22.89%763.42K15.36%614.65K0.61%663.28K
-General and administrative expense 118.57%1.23M20.69%3.08M58.40%1.21M12.87%693.74K-7.90%610.88K10.83%564.93K9.55%2.55M22.89%763.42K15.36%614.65K0.61%663.28K
Research and development costs 31.80%1.93M-14.94%5.44M-59.42%1.18M1.55%1.21M34.44%1.57M31.82%1.47M10.50%6.39M148.64%2.91M-4.70%1.2M-7.18%1.17M
Operating profit -55.93%-3.17M4.78%-8.52M34.95%-2.39M-5.39%-1.91M-19.13%-2.18M-25.22%-2.03M-10.23%-8.94M-105.07%-3.68M-1.28%-1.81M4.51%-1.83M
Net non-operating interest income expense -34.72%41.02K-37.46%221.97K-66.75%35.37K-50.04%53.93K-21.43%69.82K21.51%62.85K5,168.63%354.9K732.00%106.38K2,353.85%107.94K16,024.73%88.86K
Non-operating interest income -58.70%41.02K-23.62%271.77K-66.75%35.37K-50.04%53.93K-6.54%83.13K88.99%99.34K2,900.53%355.83K797.04%106.38K--107.94K4,191.08%88.95K
Non-operating interest expense --05,210.02%49.81K--0--014,064.89%13.32K4,223.82%36.49K-81.69%938--0--0-96.43%94
Other net income (expense)
Income before tax -58.82%-3.13M3.43%-8.29M34.01%-2.36M-8.91%-1.85M-21.19%-2.11M-25.35%-1.97M-5.94%-8.59M-100.56%-3.57M5.01%-1.7M9.16%-1.75M
Income tax
Net income -58.82%-3.13M3.43%-8.29M34.01%-2.36M-8.91%-1.85M-21.19%-2.11M-25.35%-1.97M-5.94%-8.59M-100.56%-3.57M5.01%-1.7M9.16%-1.75M
Net income continuous Operations -58.82%-3.13M3.43%-8.29M34.01%-2.36M-8.91%-1.85M-21.19%-2.11M-25.35%-1.97M-5.94%-8.59M-100.56%-3.57M5.01%-1.7M9.16%-1.75M
Minority interest income
Net income attributable to the parent company -58.82%-3.13M3.43%-8.29M34.01%-2.36M-8.91%-1.85M-21.19%-2.11M-25.35%-1.97M-5.94%-8.59M-100.56%-3.57M5.01%-1.7M9.16%-1.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.82%-3.13M3.43%-8.29M34.01%-2.36M-8.91%-1.85M-21.19%-2.11M-25.35%-1.97M-5.94%-8.59M-100.56%-3.57M5.01%-1.7M9.16%-1.75M
Basic earnings per share -35.29%-0.235.41%-0.738.71%-0.19-6.67%-0.16-20.00%-0.18-21.43%-0.17-5.71%-0.74-106.67%-0.316.25%-0.1511.76%-0.15
Diluted earnings per share -35.29%-0.235.41%-0.738.71%-0.19-6.67%-0.16-20.00%-0.18-21.43%-0.17-5.71%-0.74-106.67%-0.316.25%-0.1511.76%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Heat List
US
Overall
Symbol
Price
% Chg

No Data